STEMPOINT CAPITAL LP

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1952142 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$13,380,514

New position

Shares Held

209,234

first reported quarter

Ownership

0.134%

of shares outstanding

% of Portfolio

2.31%

of 13F equity value

Holder Rank

#46

of 266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $44,655,430 across 4 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (30.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc This page	209,234	$13,380,514
2	ALKS	Alkermes plc.	248,015	$12,995,986
3	BIOA	BioAge Labs, Inc.	464,171	$11,376,831
4	AMLX	Amylyx Pharmaceuticals, Inc.	384,304	$6,902,099

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,380,514	209,234	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.